Survey launched for 'once-in-a-lifetime' Keighley hospital
Foluke Ajayi is currently chief executive of the trust which runs Airedale Hospital, and will be in charge of building its replacement. She said: "We are committed to building a hospital that serves the needs of everyone in our community."This latest survey builds on the raft of valuable insight we have gathered so far."As part of the government's New Hospital Programme, we will be using a national template called Hospital 2.0, which incorporates the latest innovations and technology. "Combining this with the views of our patients, staff and the public will help make the most of this once-in-a lifetime opportunity, and create a hospital we can all be proud of."She added that the trust was "excited" about the future for Airedale and urged local people to "join the conversation".
Complete rebuild
Airedale Hospital was built using the controversial material known as reinforced autoclaved aerated concrete, or Raac, which has been found to be unstable and prone to collapsing.As such, the hospital was earmarked for a complete rebuild under the previous government's New Hospitals Programme - a decision later confirmed by the present government, following its review of the scheme.A meeting of Bradford Council's health and social care scrutiny committee was told, in February, that work on the rebuild is expected to begin in 2028.At the same meeting, councillors were told the scheme to replace the hospital with a new building could cost up to £1.5bn.A report prepared for the meeting said: "A capital funding envelope of between £1bn and £1.5bn has been confirmed, recognising the need to completely rebuild the hospital."Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
38 minutes ago
- Reuters
Director Francis Ford Coppola doing 'fine' after cardiac procedure in Rome
LOS ANGELES, Aug 5 (Reuters) - Francis Ford Coppola, the acclaimed American director of "The Godfather" movies and "Apocalypse Now," underwent a non-emergency cardiac procedure in a Rome hospital and is doing fine, he and a U.S.-based representative said on Tuesday. "Mr. Coppola went in for a scheduled update procedure" performed by renowned Italian-born cardiologist Dr. Andrea Natale "and is resting nicely," the representative said in response to Italian media reports that the director was hospitalised. "All is well." Coppola, 86, has been a patient of Natale for more than 30 years, the representative said. The filmmaker was admitted on Tuesday to the Policlinico Tor Vergata, a public hospital in the Italian capital, news agency ANSA reported. The U.S.-based representative declined to give any details about the nature of Coppola's medical procedure, but said: "There was not an emergency. He went to the hospital in a car. He had a scheduled appointment." Coppola posted a photograph of himself on Instagram appearing relaxed and smiling with a message reassuring fans, "I am well." "Da Dada (what my kids call me) is fine, taking an opportunity while in Rome to do the update of my 30-year-old afib procedure with its inventor, a great Italian doctor - Dr. Andrea Natale," it said. He did not elaborate further. The term "a-fib" in medical parlance is short for atrial fibrillation, a type of abnormal heart rhythm. Natale, currently the executive director of the Texas Cardiac Arrhythmia Institute, is an electrophysiology specialist who pioneered several treatments and devices for the treatment of such disorders. Coppola was in Italy to promote his latest movie, the science-fiction epic "Megalopolis," a $120 million self-funded production about a visionary architect's quest to transform a futuristic version of New York City called New Rome into a utopian community. The film, which has drawn mixed reviews and struggled at the box office following its 2024 debut at the Cannes Film Festival, was reported to have received a special screening at the Magna Graecia Film Festival in Catanzaro, Italy. The Italian-American director has won five Academy Awards, four of them for his work on the first two films in "The Godfather" trilogy, widely considered by cinema buffs to rank among the greatest movies of all time.
The Independent
6 hours ago
- The Independent
Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable
Pfizer CEO Albert Bourla announced that major pharmaceutical companies are ready to work with the Trump administration to make medicines more affordable and directly available to consumers. This move comes after Trump demanded that 17 drugmakers expand direct-to-consumer options and lower prices to match those in other industrialized countries, threatening to use 'every tool' if they did not comply. Pfizer and Bristol Myers Squibb have already revealed plans to offer their blood thinner Eliquis at a lower price online, building on Pfizer's existing direct-to-consumer telehealth and prescription services. Other companies, such as Eli Lilly and Novo Nordisk, are also exploring direct access for their obesity drugs, aiming to bypass pharmacy benefit managers. Despite potential sector-specific tariffs on pharmaceutical imports, which could escalate to 250 percent, Pfizer expects to meet its financial forecasts, though experts have refuted Trump's claims of significant drug price reductions.
Reuters
7 hours ago
- Reuters
DaVita beats quarterly profit on steady demand for dialysis services
Aug 5 (Reuters) - DaVita (DVA.N), opens new tab beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services. The company provides kidney care services for patients with chronic kidney failure through a network of outpatient clinics and at-home dialysis across the United States. DaVita, which had been grappling with rising patient care and operating costs, has also experienced disruptions from hurricanes and a ransomware attack in April, which affected some of its operations. The company said its higher IT expenses and costs tied to the cybersecurity incident led to a 10% rise in general and administrative costs from the first quarter. Earlier in the day, DaVita's peer Fresenius Medical Care ( opens new tab missed quarterly profit expectations after a severe flu season in the U.S. led to higher mortality among patients and a greater number of missed treatments earlier this year. However, DaVita reported quarterly revenue of $3.38 billion, compared to analysts' estimates of $3.36 billion, according to LSEG data. The company said it benefited from seasonal factors, including more patients meeting their co-insurance and deductibles, meaning insurance kicked in to cover treatment costs. On an adjusted basis, DaVita reported a second-quarter profit of $2.95 per share for the quarter, above analysts' estimates of $2.77 per share.
